Chronic Disease

Novartis Is Losing Its Battle Against a Generic Drug for MS

by Hayden Schmidt

On Thursday of last week, the US Supreme Court (SCOTUS) allowed the launch of generic versions of Novartis’s Gilenya, siding with China’s HEC Pharm Co and other pharmaceutical companies...

J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission

by Hayden Schmidt

Johnson & Johnson announced positive results from the VEGA Phase 2 clinical trial that paired the monoclonal antibody Tremfya (guselkumab) and the immunosuppressive drug Simponi (golimumab). The...

Pharmaceutical Industry Is Developing Almost 800 Chronic Disease Drugs

by Veronica Salib

As the rate of chronic disease in the United States continues to rise, industry members are looking for new and effective methods to manage and treat these disorders. The Pharmaceutical Research and...

Biologics and Biosimilars Intelligence Consortium Awarded $1.3 Million

by Veronica Salib

On October 3, 2022, the FDA awarded the Biologics and Biosimilars Collective Intelligence (BBIC) a $1.3 million grant to be paid out in the next two years. The grant is intended to fund a study on...

FDA Approves Drug for Open-Angle Glaucoma and Ocular Hypertension

by Veronica Salib

In a recent press release, Santen announced that the FDA approved OMLONTI, the company’s newest ophthalmic medication. This ophthalmic solution is composed of 0.002% omidenepag isopropyl. This...

Fish Oil Supplements Associated with Risk of Atrial Fibrillation

by Veronica Salib

Many vitamins and supplements are readily available over the counter for patient use. Understanding the effects of supplements on healthcare can impact and inform physician practices for more effective...

FDA Approves Relyvrio for ALS Treatment

by Veronica Salib

Yesterday, the FDA approved Relyvrio, an ALS drug developed by Amylyx Pharmaceuticals, after extensive discussions about the safety and efficacy of the drug. The drug was initially rejected by an FDA...

How Federal and State Laws Have Hindered Access to OUD Treatment

by Veronica Salib

The opioid epidemic has persisted over the past few decades. Exacerbated by the pharmaceutical industry, this epidemic has left many struggling with opioid use disorder (OUD). Effective treatments for...

How Antirejection Drugs Can Promote Successful Transplants

by Veronica Salib

The United Network for Organ Sharing (UNOS) states that, as of July 2022, there have been 24,414 organ transplants this year in the United States alone. Considering the limitations on the number of organs available for transplant and the...

FDA Approved the Use of Omnipod 5 for Children Over 2

by Veronica Salib

In January 2022, Omnipod 5 was first approved for anyone over six. Omnipod 5 is the first tubeless automated insulin delivery (AID) made available in the United States for a broad age range. Recently,...

Understanding the Burdens of Dialysis

by Veronica Salib

Chronic kidney disease (CKD) occurs when the kidneys fail to filter waste as they typically do in a healthy body. Patients in the late stage of chronic kidney disease progress to end-stage renal failure (ESRF) when they need a transplant...

A History of Insulin Development and Insulin Delivery Systems

by Veronica Salib

In recent years, the costs of prescription drugs have increased dramatically. One of the most notable drugs with high prices is insulin. Understanding the basic uses of insulin and common delivery methods may contribute to an in-depth...

Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge

by Hayden Schmidt

Pfizer is back at it with another acquisition, this time scooping up the rare disease pharmaceutical company Global Blood Therapeutics for $5.4 billion in cash. Pfizer’s acquisition will cede...

Researchers Discover Promising Compound That Kills Hard-to-Treat Cancer Cells

by Alivia Kaylor

Scientists from the University of Texas Health Science Center at San Antonio have found a new target for eradicating various hard-to-treat cancer cells in culture and animal models, which could...

FDA Approves First Drug for Chronic Disease Eosinophilic Esophagitis

by Hayden Schmidt

Sanofi’s Dupixent received FDA approval for use in people suffering from eosinophilic esophagitis (EoE) after a double-blind, placebo-controlled trial proved the drug effectively reduces...

Major Milestones in Medicine, Drug Development in Recorded History

by Alivia Kaylor

Because the past few centuries have witnessed several revolutionary scientific advances, research into the mechanisms responsible for infectious diseases and the development of drugs and vaccines has led to the eradication of...